Prognostic value of inflammation‐related biomarkers in patients with gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta‐analysis

Documenti analoghi

• Incidence of gastroenteropancreatic neuroendocrine neoplasms (GEP‐NENs): An updated systematic review of population‐based reports from 2010 to 2023
  di: Magnus Andreas Nordstrand, et al.
  Pubblicazione: (2025)
• Peptide receptor radionuclide therapy with somatostatin analogs beyond gastroenteropancreatic neuroendocrine tumors
  di: Giulia Santo, et al.
  Pubblicazione: (2025)
• Current status of peptide receptor radionuclide therapy in grade 1 and 2 gastroenteropancreatic neuroendocrine tumours
  di: Jelka Kuiper, et al.
  Pubblicazione: (2024)
• The global leadership into malnutrition criteria reveals a high percentage of malnutrition which influences overall survival in patients with gastroenteropancreatic neuroendocrine tumours
  di: Dominique S. V. M. Clement, et al.
  Pubblicazione: (2024)
• The geographical distribution of neuroendocrine neoplasms in England (2012–2018)
  di: Chinonso A. Nwoguh, et al.
  Pubblicazione: (2025)